CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-06 | RAPP MICHAEL Director | Purchase | +83,332 | $12.00 | $1000K | 638,886 |
| 2020-10-06 | RAPP MICHAEL Director | Conversion · Series A Convertible Preferred Stock | −555,554 | 0 | ||
| 2020-10-06 | RAPP MICHAEL Director | Conversion · Warrant (right to buy) | −166,666 | 0 | ||
| 2020-10-06 | RAPP MICHAEL Director | Conversion · Warrant (right to buy) | +166,666 | 166,666 | ||
| 2020-10-06 | MORRIS I WISTAR III 10% owner | Conversion | +882,475 | 882,475 | ||
| 2020-10-06 | MORRIS I WISTAR III 10% owner | Conversion | +38,464 | 38,464 | ||
| 2020-10-06 | MORRIS I WISTAR III 10% owner | Conversion · Series A Convertible Preferred Stock | −882,475 | 0 | ||
| 2020-10-06 | MORRIS I WISTAR III 10% owner | Conversion · Series A Convertible Preferred Stock | −38,464 | 0 | ||
| 2020-10-06 | MORRIS I WISTAR III 10% owner | Conversion · Warrant (right to buy) | −111,111 | 0 | ||
| 2020-10-06 | MORRIS I WISTAR III 10% owner | Conversion · Warrant (right to buy) | +111,111 | 111,111 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion | +22,222 | 22,222 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion · Series A Convertible Preferred Stock | −22,222 | 0 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion · Warrant (right to buy) | −11,111 | 0 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion · Warrant (right to buy) | +11,111 | 11,111 | ||
| 2020-10-06 | LAMATTINA JOHN L Director | Conversion | +46,388 | 46,388 | ||
| 2020-10-06 | LAMATTINA JOHN L Director | Conversion · Series A Convertible Preferred Stock | −46,388 | 0 | ||
| 2020-10-06 | LAMATTINA JOHN L Director | Conversion · Warrant (right to buy) | −11,111 | 0 | ||
| 2020-10-06 | LAMATTINA JOHN L Director | Conversion · Warrant (right to buy) | +11,111 | 11,111 | ||
| 2020-10-01 | Fitzgerald Richard F Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +104,802 | 104,802 | ||
| 2020-10-01 | Fitzgerald Richard F Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +7,681 | 7,681 |
Page 12 of 12 · 240 trades